Guardant Health, Inc. (GH)

Guardant Health Stock Forecast

Stock Price Forecast

The 19 analysts that cover Guardant Health stock have a consensus rating of "Strong Buy" and an average price target of $119.79, which forecasts a 33.34% increase in the stock price over the next year. The lowest target is $60 and the highest is $180.

Price Target: $119.79 (+33.34%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$60	$119.79	$130	$180
Change	-33.21%	+33.34%	+44.70%	+100.36%

Analyst Ratings

The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	8	8	7	7	7	7
Buy	13	12	12	12	11	11
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	21	21	20	20	19	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luke Sergott Barclays	Barclays	Buy Maintains $130 → $115	Buy	Maintains	$130 → $115	+28.01%	Apr 14, 2026
Daniel Markowitz Evercore ISI Group	Evercore ISI Group	Hold Maintains $110 → $90	Hold	Maintains	$110 → $90	+0.18%	Apr 6, 2026
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $120 → $130	Buy	Maintains	$120 → $130	+44.70%	Feb 24, 2026
Puneet Souda Leerink Partners	Leerink Partners	Buy Maintains $170 → $180	Buy	Maintains	$170 → $180	+100.36%	Feb 20, 2026
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $135 → $150	Strong Buy	Maintains	$135 → $150	+66.96%	Feb 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.31B

Increased by 33.30%

from 982.02M

Revenue Next Year

1.68B

Increased by 28.34%

from 1.31B

EPS This Year

-2.86

from -3.32

EPS Next Year

-1.89

from -2.86

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	373.65M	449.54M	563.95M	739.02M	982.02M	1.31B	1.68B
Revenue Growth	30.32%	20.31%	25.45%	31.04%	32.88%	33.30%	28.34%
EPS	-4.00	-6.41	-4.28	-3.56	-3.32	-2.86	-1.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	28	28

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	1.4B	1.9B
Avg	1.3B	1.7B
Low	1.2B	1.5B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	39.0%	47.0%
Avg	33.3%	28.3%
Low	25.9%	16.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031	2032	2033
High	-1.27	0.38
Avg	-2.86	-1.89
Low	-3.11	-2.61

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.